Optimizing Radiotherapy Timing for Nasopharyngeal Carcinoma: The Impact of Radiation Scheduling on Survival We performed a single-institution retrospective analysis of patients with R/M HNSCC treated ...
LEO Pharma will be gaining the rights to commercialise Junshi Biosciences’ toripalimab in Europe under a new distribution and ...
Leo Pharma has stepped up to commercialize toripalimab in Europe, inking a deal with Shanghai Junshi Biosciences to secure ...
Junshi Biosciences and TopAlliance are set to enter a collaboration with LEO Pharma to distribute and market toripalimab in ...
Camille Prats’ eldest son Nathan turned 17 and she marked the occasion with a heartfelt letter. The “Mommy Dearest” actress ...
Nasal cancer, which is also known as nasopharyngeal cancer, affects the nasopharynx, the upper part of the throat and can be easily mistaken for other problems ...
Researchers have discovered how a particular protein affects the growth and spread of colon cancer in humans. The study not ...
China-based Kelun-Biotech Biopharmaceutical has received marketing authorization in China from National Medical Products Administration (NMPA) for the programmed cell death ligand 1(PD-L1)-directed ...
Revlimid has arguably been the single biggest growth driver for Dr Reddy's in recent years, fueling record-high US sales last ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback